CUSIP 09073Q204
BIONDVAX PHARMACEUTICALS LTD
18 institutions · $227.0K total · 430,393 shares
| # | Manager | Shares | Value | % of Total | Period |
|---|---|---|---|---|---|
| 1 | SABBY MANAGEMENT, LLC | 253,135 | $131.4K | 58.81% | 2024-03-31 |
| 2 | ARMISTICE CAPITAL, LLC | 121,785 | $63.2K | 28.29% | 2024-03-31 |
| 3 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10,921 | $14.9K | 2.53% | 2023-09-30 |
| 4 | CITADEL ADVISORS LLC | 12,214 | $6.3K | 2.83% | 2024-03-31 |
| 5 | MILLENNIUM MANAGEMENT LLC | 10,613 | $5.5K | 2.46% | 2024-03-31 |
| 6 | RHUMBLINE ADVISERS | 6,654 | $3.4K | 1.54% | 2024-03-31 |
| 7 | MORGAN STANLEY | 1,879 | $975 | 0.43% | 2024-09-30 |
| 8 | UBS Group AG | 1,817 | $943 | 0.42% | 2024-03-31 |
| 9 | Credit Agricole S A | 424 | $193 | 0.09% | 2024-03-31 |
| 10 | Main Street Group, LTD | 200 | $103 | 0.04% | 2024-03-31 |
| 11 | Aspire Private Capital, LLC | 160 | $83 | 0.03% | 2024-03-31 |
| 12 | Global Retirement Partners, LLC | 50 | $26 | 0.01% | 2024-03-31 |
| 13 | Virtu Financial LLC | 10,508 | $23 | 2.44% | 2023-06-30 |
| 14 | WELLS FARGO & COMPANY/MN | 20 | $17 | 0.00% | 2023-12-31 |
| 15 | Qube Research & Technologies Ltd | 7 | $4 | 0.00% | 2024-03-31 |
| 16 | NewSquare Capital LLC | 2 | $3 | 0.00% | 2023-09-30 |
| 17 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% | 2024-03-31 |
| 18 | Royal Bank of Canada | 4 | $0 | 0.00% | 2024-09-30 |